Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies.
Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie B, Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M, Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW. Kirtane AJ, et al. Among authors: saia f. Circulation. 2009 Jun 30;119(25):3198-206. doi: 10.1161/CIRCULATIONAHA.108.826479. Epub 2009 Jun 15. Circulation. 2009. PMID: 19528338
Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases.
Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K, Hoye A, Degertekin M, Daemen J, McFadden E, Hofma S, Smits PC, de Feyter P, van der Giessen WJ, van Domburg RT, Serruys PW. Lemos PA, et al. Among authors: saia f. Circulation. 2003 Jul 22;108(3):257-60. doi: 10.1161/01.CIR.0000083366.33686.11. Epub 2003 Jul 14. Circulation. 2003. PMID: 12860901 Clinical Trial.
Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study.
Saia F, Lemos PA, Lee CH, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Sianos G, Smits PC, McFadden E, Hofma SH, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW. Saia F, et al. Circulation. 2003 Oct 21;108(16):1927-9. doi: 10.1161/01.CIR.0000096053.87580.CD. Epub 2003 Oct 13. Circulation. 2003. PMID: 14557354 Clinical Trial.
Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.
Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Daemen J, Liu TK, McFadden E, Sianos G, Hofma SH, Smits PC, van der Giessen WJ, de Feyter PJ. Lemos PA, et al. Among authors: saia f. Circulation. 2004 Jan 20;109(2):190-5. doi: 10.1161/01.CIR.0000109138.84579.FA. Epub 2003 Dec 22. Circulation. 2004. PMID: 14691037 Clinical Trial.
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A. Marzocchi A, et al. Among authors: saia f. Circulation. 2007 Jun 26;115(25):3181-8. doi: 10.1161/CIRCULATIONAHA.106.667592. Epub 2007 Jun 11. Circulation. 2007. PMID: 17562952
Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
Ortolani P, Balducelli M, Marzaroli P, Piovaccari G, Menozzi A, Guiducci V, Sangiorgio P, Tarantino F, Geraci G, Castriota F, Tondi S, Saia F, Cooke RM, Guastaroba P, Grilli R, Marzocchi A, Maresta A. Ortolani P, et al. Among authors: saia f. Circulation. 2008 Feb 19;117(7):923-30. doi: 10.1161/CIRCULATIONAHA.107.730416. Epub 2008 Feb 4. Circulation. 2008. PMID: 18250265
The safety of drug-eluting stents.
Saia F, Marzocchi A, Branzi A. Saia F, et al. Ther Adv Cardiovasc Dis. 2008 Feb;2(1):43-52. doi: 10.1177/1753944707088158. Ther Adv Cardiovasc Dis. 2008. PMID: 19124407 Free article. Review.
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials.
Valgimigli M, Biondi-Zoccai G, Tebaldi M, van't Hof AW, Campo G, Hamm C, ten Berg J, Bolognese L, Saia F, Danzi GB, Briguori C, Okmen E, King SB, Moliterno DJ, Topol EJ. Valgimigli M, et al. Among authors: saia f. Eur Heart J. 2010 Jan;31(1):35-49. doi: 10.1093/eurheartj/ehp376. Epub 2009 Sep 14. Eur Heart J. 2010. PMID: 19755402 Review.
New-generation drug-eluting stents reduce stent thrombosis and myocardial infarction: a propensity-score-adjusted analysis from the multicenter REAL registry (REgistro Regionale AngiopLastiche Dell'Emilia-Romagna).
Vignali L, Saia F, Belotti LM, Solinas E, Guastaroba P, Rubboli A, Manari A, Mehran R, Ardissino D, De Palma R. Vignali L, et al. Among authors: saia f. Catheter Cardiovasc Interv. 2015 Apr;85(5):797-806. doi: 10.1002/ccd.25675. Epub 2014 Oct 14. Catheter Cardiovasc Interv. 2015. PMID: 25256440
Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients With Coronary Stent: How Important Is the Interplay Between Stent Type and Time From Stenting to Surgery?
Saia F, Belotti LM, Guastaroba P, Berardini A, Rossini R, Musumeci G, Tarantini G, Campo G, Guiducci V, Tarantino F, Menozzi A, Varani E, Santarelli A, Tondi S, De Palma R, Rapezzi C, Marzocchi A. Saia F, et al. Circ Cardiovasc Qual Outcomes. 2016 Jan;9(1):39-47. doi: 10.1161/CIRCOUTCOMES.115.002155. Epub 2015 Dec 8. Circ Cardiovasc Qual Outcomes. 2016. PMID: 26646819
353 results